[{"Assets_0_Q3_USD":893964000.0,"CommonStockSharesOutstanding_0_Q3_shares":87211000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-33655000.0,"NetIncomeLoss_1_Q3_USD":-49439000.0,"NetIncomeLoss_3_Q3_USD":21153000.0,"StockholdersEquity_0_Q3_USD":594447000.0,"EarningsPerShareBasic_1_Q3_USD":-0.57,"EarningsPerShareBasic_3_Q3_USD":0.24,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":87007000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":86390000.0,"Ticker":"FGEN","CIK":"921299","name":"FIBROGEN INC","OfficialName":"FibroGen Inc Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"987680900.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191112"}]